Developing a vaccine for the deadly COVID-19 virus is one of the most urgent needs in the global fight to curb the pandemic.
A team of researchers at Western University has set out to do just that, working to establish and test an effective vaccine.
Led by Eric Arts and fellow Schulich researchers Stephen Barr, Chil-Yong Kang and Ryan Troyer, the team is also developing a “vaccine bank” to contain ready-made vaccines that can be used rapidly at the start of another coronavirus outbreak.
“An effective vaccine will have a tremendous impact on stopping the spread of the virus or alleviating the symptoms of the disease in infected individuals,” said Barr. “In the face of an outbreak like this one, putting together collaborative teams and working with other labs across the country is critically important for giving Canada the greatest chance to effectively control and manage this pandemic.”
Western’s efforts are being conducted within a Containment Level 3 lab inside the recently constructed Imaging Pathogens for Knowledge Translation (ImPaKT) facility.
For more information, visit Western University.